All Stories

  1. IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer
  2. IMMUNOREACT 13: immune features of healthy rectal mucosa as predictors of invasion risk in stage II rectal cancer
  3. Reply to comments to “IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer”
  4. Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management
  5. Leaving behind a diseased small bowel during surgery for Crohn’s disease: Long-term outcomes
  6. Predictors of urinary tract infection after lower gastrointestinal surgery
  7. IMMUNOREACT 0: Biopsy‐based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer—A systematic review and meta‐analysis
  8. Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review
  9. IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer
  10. Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?
  11. Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells
  12. The impact of COVID-19 pandemic on access to medical services and its consequences on emergency surgery
  13. Treatment and Prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysis
  14. Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinoma
  15. IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients – a cohort study
  16. Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
  17. Rectal Sparing Approaches after Neoadjuvant Treatment for Rectal Cancer: A Systematic Review and Meta-Analysis Comparing Local Excision and Watch and Wait
  18. Tumor immune microenvironment in therapy‐naive esophageal adenocarcinoma could predict the nodal status
  19. Chemoradiation vs. local excision in the management of early squamous cell carcinoma of the anus: a systematic review
  20. Molecular Determinants of Peritoneal Dissemination in Gastric Adenocarcinoma
  21. Validation of the Padova Prognostic Score for Colitis in Predicting Long-Term Outcome After Restorative Proctocolectomy
  22. Biohumoral Predictors of Advanced Pancreatic Carcinoma Not Shown at Pre-operative Imaging
  23. Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer
  24. Metachronous colorectal cancer have a similar microsatellite instability frequency but a lower infiltration of lymphomononuclear cells than primary lesions
  25. Reply to: “The strength of a randomized controlled trial lies in its design—randomization”
  26. Discrimination Toward Women in Surgery
  27. Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway
  28. Could Total Neoadjuvant Therapy Followed by Surgical Resection Be the New Standard of Care in Pancreatic Cancer? A Systematic Review and Meta-Analysis
  29. Impact on Quality of Life of Seton Placing in Perianal Crohn's Disease
  30. Crohn’s Disease-Related Stoma Complications and Their Impact on Postsurgical Course
  31. Totally Implantable Venous Access Devices: A Randomized Controlled Trial on the Effect of Psychological Support on Quality of Life and Body Image (BI-PORT)
  32. Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management
  33. How a modified Nissen procedure works: a mechanistic study using intraoperative esophageal high-resolution manometry
  34. Epstein-Barr virus associated gastric dysplasia: a new rare entity?
  35. Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases
  36. Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study
  37. Persistent Herpes Simplex Virus Type 1 Infection of Enteric Neurons Triggers CD8+ T Cell Response and Gastrointestinal Neuromuscular Dysfunction
  38. MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer
  39. Prevention Strategies for Esophageal Cancer—An Expert Review
  40. Moderately differentiated esophageal squamous cell carcinoma has a poor prognosis after neoadjuvant chemoradiotherapy
  41. Esophageal squamous cell carcinoma metachronous to head and neck cancers
  42. CD80 expression is upregulated by TP53 activation in human cancer epithelial cells
  43. Oligometastatic Pancreatic Cancer to the Liver in the Era of Neoadjuvant Chemotherapy: Which Role for Conversion Surgery? A Systematic Review and Meta-Analysis
  44. Laparoscopic Ventral Rectopexy for Obstructed Defecation: Functional Results and Quality of Life
  45. Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
  46. QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancer
  47. Correction to: Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis
  48. SARS-CoV-2 containment in complex surgical units during the COVID-19 pandemic
  49. Lasting Symptoms After Esophageal Resection (LASER)
  50. Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett’s carcinogenesis
  51. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis
  52. Can Vascular Endothelial Growth Factors and CD34 Expression Implement NICE (Narrow-Band Imaging International Colorectal Endoscopic) Classification in Colorectal Polypoid Lesion Diagnosis?
  53. Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response
  54. PD-L1 expression in gastroesophageal dysplastic lesions
  55. Inflammatory Bowel Disease Therapies Adversely Affect Fertility in Men- A Systematic Review and Meta-analysis
  56. Interferon-Gamma and Tumor Necrosis Factor-Related Weak Inducer of Apoptosis Expression in Neoangiogenesis in Colorectal Polypoid Lesions
  57. Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
  58. Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery
  59. PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
  60. Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis
  61. Diffusion-weighted magnetic resonance for assessing fibrosis in Crohn’s disease
  62. CD80 expression promotes immune surveillance in Barrett’s metaplasia
  63. Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis
  64. Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis
  65. Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases
  66. Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells
  67. S quamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity
  68. A Case of Carcinosarcoma of the Gastroesophageal Junction With Neuroendocrine and Chondroid Differentiation
  69. Psychological support of esophageal cancer patient?
  70. Human papillomavirus infection is not involved in esophageal verrucous carcinoma
  71. Electrochemotherapy – Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration
  72. miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis
  73. Cholecystectomy during esophagectomy is safe but unnecessary
  74. Herpes Simplex Virus Type 1 Engages Toll Like Receptor 2 to Recruit Macrophages During Infection of Enteric Neurons
  75. Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
  76. Esophageal cancer patients’ information management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information
  77. Correction: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression
  78. Effects of immune suppression for transplantation on inflammatory colorectal cancer progression
  79. Antibacterial efficacy and mechanisms of action of low power atmospheric pressure cold plasma: membrane permeability, biofilm penetration and antimicrobial sensitization
  80. Time to diagnosis in esophageal cancer: a cohort study
  81. Herpes Simplex Virus Type 1 Infects Enteric Neurons and Triggers Gut Dysfunction via Macrophage Recruitment
  82. Long-term quality of life after esophagectomy with gastric pull-up
  83. Esophageal Cancer Clinical Presentation
  84. Potential curability and perception of received information in esophageal cancer patients
  85. Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance
  86. Immunonutrition before esophagectomy: Impact on immune surveillance mechanisms
  87. miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma
  88. A systematic review of segmental vs subtotal colectomy and subtotal colectomy vs total proctocolectomy for colonic Crohn's disease
  89. Colorectal cancer in the young: a possible role for immune surveillance?
  90. Angiogenesis inhibitors and symptomatic anal ulcers in metastatic colorectal cancer patients
  91. Randomized clinical trial of psychological support and sleep adjuvant measures for postoperative sleep disturbance in patients undergoing oesophagectomy
  92. PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions
  93. Angiogenesis inhibitor bevacizumab and symptomatic anal ulcers in metastatic colorectal cancer patients: A single center experience.
  94. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study
  95. The molecular landscape of colitis-associated carcinogenesis
  96. Colorectal polypoid lesions and expression of vascular endothelial growth factor in a consecutive series of endoscopic and surgical patients
  97. Early miR-223 Upregulation in Gastroesophageal Carcinogenesis
  98. Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy
  99. Hedgehog signaling in colorectal cancer: a spiny issue gets smoothened
  100. Applied investigation of person-specific and context-specific factors on postoperative recovery and clinical outcomes of patients undergoing gastrointestinal cancer surgery: multicentre European study
  101. CD80 down-regulation is associated to aberrant DNA methylation in non-inflammatory colon carcinogenesis
  102. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer
  103. Mo1760 Crohn's Disease Recurrence After Ileocolonic Resection: High Expression of TLR2 and TLR4 is Associated to Prolonged Disease Free Interval
  104. Su1750 Crohn's Disease Recurrence After Ileocolonic Resection: Higher BDNF Levels in Healthy Ileum Is Associated to a Longer Recurrence-Free Interval
  105. Mo1221 Esophageal Cancer Patients Management: Cross-Cultural Differences Between Dutch and Italian Patients in Perceived Quality of Provided Oncological Information
  106. Su1153 Information Providing to Patients With Esophageal Cancer in a Tertiary Referral Center
  107. Tu1863 TLR4 and MyD88 and Mismatch Repair Genes in Colorectal Cancer
  108. Tu1867 The Capability of Antigen Presentation of Colonic Epithelial Cells Is Essential to Activate an Effective CD8 Response During the Early Phases of the Carcinogenic Progression
  109. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC
  110. Impact of esophagectomy for cancer on patients' occupational status
  111. The Role of Surgery in Patients With a Complete Clinical Response After Chemoradiation for Esophageal Cancer
  112. Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance
  113. Hybrid minimally invasive esophagectomy for cancer: impact on postoperative inflammatory and nutritional status
  114. Health related quality of life after oesophagectomy: elderly patients refer similar eating and swallowing difficulties than younger patients
  115. TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn's disease
  116. Postoperative outcome after oesophagectomy for cancer: Nutritional status is the missing ring in the current prognostic scores
  117. Esophagectomy in elderly patients: which is the best prognostic score?
  118. Esophageal adenocarcinoma and obesity: peritumoral adipose tissue plays a role in lymph node invasion
  119. Systematic review of surgical treatment of subclinical Cushing's syndrome
  120. Palliative therapy for esophageal cancer: laser therapy alone is associated with a better functional outcome
  121. CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis
  122. Intestinal Surgery for Crohn's Disease: Role of Preoperative Therapy in Postoperative Outcome
  123. The effects of acupuncture after thyroid surgery: A randomized, controlled trial
  124. Complications after surgery for colorectal cancer affect quality of life and surgeon-patient relationship
  125. Role of Proton Pump Inhibitor on Esophageal Carcinogenesis and Pancreatic Acinar Cell Metaplasia Development: An Experimental In Vivo Study
  126. Oesophageal cancer: assessment of tumour response to chemoradiotherapy with tridimensional CT
  127. Esophageal Cancer Management: Preoperative CA19.9 and CEA Serum Levels May Identify Occult Advanced Adenocarcinoma
  128. Diffusion-Weighted Magnetic Resonance for Assessing Ileal Crohnʼs Disease Activity
  129. Detailed study of the K ± → π 0 π 0 e ± ν (K e4 00 ) decay properties
  130. MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma
  131. Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution
  132. The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis
  133. Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis
  134. Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis
  135. Sleep disturbances and quality of life in postoperative management after esophagectomy for esophageal cancer
  136. Minimally invasive treatment of peristomal metastases from gastric cancer at an ileostomy site by electrochemotherapy
  137. Minimally invasive surgery for esophageal cancer: a review on sentinel node concept
  138. Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary?
  139. The Effect of Dichotomizing Age in Outcomes Assessment of the Surgical Management of Esophageal Cancer
  140. Minimally invasive surgery for colorectal cancer: quality of life and satisfaction with care in elderly patients
  141. More information about the pattern of lymphatic spread could improve the effectiveness of surgery for esophageal cancer
  142. Low Perioperative Serum Prealbumin Predicts Early Recurrence After Curative Pulmonary Resection for Non-Small-Cell Lung Cancer
  143. Health-Related Quality of Life in Patients with Oesophageal Cancer: Analysis at Different Steps of the Treatment Pathway
  144. Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4–NFκB signalling
  145. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis
  146. What is the optimal management of dysphagia in metastatic esophageal cancer?
  147. Does Obesity Affect Outcomes in Patients Undergoing Esophagectomy for Cancer? Comments on a Meta-analysis
  148. Overweight Patients Operated on for Cancer of the Esophagus Survive Longer than Normal-Weight Patients
  149. Intraoperative Blood Transfusion Contributes to Decreased Long-Term Survival of Patients with Esophageal Cancer: Comments on Regression Model Estimation
  150. Cost-Effectiveness Analysis of Postoperative Surveillance Protocols Following Radical Surgery for Colorectal Cancer
  151. Innate Immune Environment in Ileal Pouch Mucosa: α5 Defensin Up-regulation as Predictor of Chronic/Relapsing Pouchitis
  152. TLR2 and TLR4 Up-regulation and Colonization of the Ileal Mucosa by Clostridiaceae spp. in Chronic/Relapsing Pouchitis
  153. Magnetic Resonance Enterography for Crohn’s Disease: What the Surgeon Can Take Home
  154. Relationship between mucosa-associated microbiota and inflammatory parameters in the ileal pouch after restorative proctocolectomy for ulcerative colitis
  155. Nodal Metastasis From Locally Advanced Esophageal Cancer: How Neoadjuvant Therapy Modifies Their Frequency and Distribution
  156. Complete Response After Neoadjuvant Chemoradiotherapy for Cancer of the Thoracic Esophagus and Esophago-Gastric Junction: Prognostic Significance and Clinical Implications
  157. Mucosal Immune Environment in Colonic Carcinogenesis: T-Cell Activation in Ulcerative Colitis and Dysplasia
  158. Mucosal immune environment in colonic carcinogenesis: CD80 up-regulation in colonic dysplasia in ulcerative colitis
  159. Long-term health-related quality of life after minimally invasive surgery for diverticular disease
  160. New measurement of the K±→π±
  161. Systematic review of health-related quality of life after esophagectomy for esophageal cancer
  162. Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitis
  163. Perianal Crohn’s disease: Is there something new?
  164. Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia
  165. A systematic review on advancement flaps for rectovaginal fistula in Crohn’s disease: transrectal vs transvaginal approach
  166. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
  167. Diode laser treatment of Barrett’s esophagus: long-term results
  168. A systematic review of diagnostic procedures to detect midgut neuroendocrine tumors
  169. Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis
  170. Clinical Presentation and Diagnosis of Intestinal Adenocarcinoma in Crohn’s Disease: Analysis of Clinical Predictors and of the Life-Time Risk
  171. Measurement of the direct emission and interference terms and search for CP violation in the decay K ±→π ± π 0 γ
  172. Ileal neuroendocrine carcinoma following restorative proctocolectomy for colonic adenocarcinoma in Crohn's disease
  173. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
  174. P.60 HOMING SIGNALS OF ENDOTHELIAL PROGENITORS CELLS IN IBD PATIENTS
  175. Stapled haemorrhoidopexy: extent of tissue excision and clinical implications in the early postoperative period
  176. Deep Venous Thrombosis After Surgery for Inflammatory Bowel Disease: Is Standard Dose Low Molecular Weight Heparin Prophylaxis Enough?
  177. Quality of life after surgery of the alimentary tract
  178. Health related quality of life after surgery for colonic diverticular disease
  179. Subclinical Intestinal Inflammation in Patients with Crohn’s Disease Following Bowel Resection: A Smoldering Fire
  180. Intestinal Surgery for Crohn’s Disease: Predictors of Recovery, Quality of Life, and Costs
  181. The hostile neck does not increase the risk of carotid endarterectomy
  182. Reduced Endothelial Progenitor Cell Number and Function in Inflammatory Bowel Disease: A Possible Link to the Pathogenesis
  183. Restorative proctocolectomy for inflammatory bowel disease
  184. Diverting loop ileostomy after restorative proctocolectomy: predictors of poor outcome and poor quality of life
  185. TGF-β1 and IGF-1 Production and Recurrence of Crohn's Disease After Ileo-Colonic Resection
  186. Plasma lipids and inflammation in active inflammatory bowel diseases
  187. Inflammatory Fibroid Polyp Causing Intestinal Obstruction following Restorative Proctocolectomy for Ulcerative Colitis
  188. Validation of an English Version of the Padova Quality of Life Instrument to Assess Quality of Life Following Ileal Pouch Anal Anastomosis
  189. Cytokine network in rectal mucosa in perianal Crohnʼs disease: Relations with inflammatory parameters and need for surgery
  190. A systematic review on the clinical diagnosis of gastrointestinal stromal tumors
  191. Health-Related Quality of Life after Colonic Resection for Diverticular Disease: Long-term Results
  192. TGF-β1 and IGF-1 and Anastomotic Recurrence of Crohn’s Disease After Ileo-Colonic Resection
  193. Double contrast small-bowel radiography in the preoperative assessment of Crohn’s disease: Is it still useful?
  194. Lipid and phospholipid profile after bowel resection for Crohn’s disease
  195. Minimally invasive surgery for colorectal cancer: quality of life, body image, cosmesis, and functional results
  196. PA.165 CYTOKINE NETWORK IN RECTAL MUCOSA IN PERIANAL CROHN'S DISEASE: RELATIONS WITH INFLAMMATORY PARAMETERS AND NEED FOR SURGERY
  197. PA.59 HEALTH RELATED QUALITY OF LIFE AND CLINICAL OUTCOME AFTER COLONIC RESECTION FOR DIVERTICULAR DISEASE: LONG-TERM RESULTS
  198. OC3.03.9 LONG TERM OUTCOME AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY IN A COHORT OF 955 CANADIAN PATIENTS
  199. PA.175 RESTORATIVE PROCTOCOLECTOMY FOR INFLAMMATORY BOWEL DISEASE: IS PRE-OPERATIVE DIAGNOSIS A PREDICTOR OF LONG TERM OUTCOME AND HEALTH RELATED QUALITY OF LIFE?
  200. New high statistics measurement of Ke4 decay form factors and ππ scattering phase shifts
  201. B1a Lymphocytesʼ expression in the rectum of ulcerative colitis patients
  202. First observation and measurement of the decay K±→π±<...
  203. Gastrointestinal telangiectasia: a study by EGD, colonoscopy, and capsule endoscopy in 75 patients
  204. Endoscopic Dilation of Benign Esophageal Strictures in a Surgical Unit
  205. Restorative Proctocolectomy for Ulcerative Colitis: Impact on Lipid Metabolism and Adipose Tissue and Serum Fatty Acids
  206. Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohnʼs Disease
  207. Surgical predictors of recurrence of Crohn’s disease after ileocolonic resection
  208. Enzymes in feces: Useful markers of chronic inflammatory bowel disease
  209. Health-Related Quality of Life after Ileocolonic Resection for Crohnʼs Disease: Long-term Results
  210. B1a lymphocytes in ulcerative colitis
  211. The P326 (NA48/3) Gigatracker: Requirements and design concept
  212. Adenocarcinoma after restorative proctocolectomy for cancer in ulcerative colitis
  213. Quality of Life After Restorative Proctocolectomy for Ulcerative Colitis
  214. Cytokine Network in Chronic Perianal Crohn’s Disease and Indeterminate Colitis After Colectomy
  215. Decision making for metastatic diseases to the ovaries from colorectal cancer
  216. Ovarian metastasis from colorectal cancer: Prognostic value of radical oophorectomy
  217. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis
  218. Rod in loop ileostomy: just an insignificant detail for ileostomy-related complications?
  219. Expression of costimulatory molecule CD80 in colonic dysplasia in ulcerative colitis: an immunosurveillance mechanism against colorectal cancer?
  220. Are frozen sections useful and cost-effective in the era of intraoperative qPTH assays?
  221. A Gastrocolic Fistula in Crohn’s Disease
  222. Ileostomy for constipation: long-term postoperative outcome
  223. Unusual cause of small bowel perforation: metastasis of a subcutaneous angiosarcoma of the head
  224. Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis
  225. Early Surgery for the Treatment of Toxic Megacolon
  226. Effects of iron manipulation on trace elements level in a model of colitis in rats
  227. The Role of Costimulatory Molecules CD80 and CD86 and IFNγ in the Pathogenesis of Ulcerative Colitis
  228. Minimally Invasive Management of Crohn's Disease Complicated by Ureteral Stenosis
  229. Observation of the rare decay KS→π0
  230. Measurement of the branching ratio and form factors for the decay KL→π±π0e∓νe(ν̄e)
  231. The drift chamber electronics for the NA48 experiment
  232. Effects of iron deprivation or chelation on DNA damage in experimental colitis
  233. Health-related quality of life after restorative proctocolectomy for ulcerative colitis: Long-term results
  234. A new drift chamber TDC readout for the high intensity program of the NA48 experiment
  235. Observation of the rare decay KS→π0e+e−
  236. Effects of iron manipulation on trace elements status in DNBS-induced colitis
  237. The drift chamber electronics for the NA48 experiment
  238. The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation
  239. Life table analysis of hernia following end colostomy construction